Evaluation Study of Early Administration of Evolocumab After Thrombolysis in Patients With Atherosclerotic Acute Ischemic Stroke

NCT07301372 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

132

Enrollment

OTHER

Sponsor class

Conditions

Acute Stroke

Interventions

DRUG: Ivolumab 420mg (three vials)

Sponsor

The Affiliated Hospital of Xuzhou Medical University